A recent study by Yamashita et al. in human IDH-mutant glioma cell lines found not only that azacitidine reduced cellular proliferation and induced increased expression of astroglial differentiation markers like GFAP, but also that azacitidine worked synergistically with temozolomide to inhibit tumor growth (123). Here, IDH2 is linked to glioma.